Fluoxetine/olanzapine

A major metabolite of clozapine used in designer receptor exclusively activated by designer drug, also known as DREADD, technology to modulate synthetic receptors in vivo.

A major metabolite of clozapine used in designer receptor exclusively activated by designer drug, also known as DREADD, technology to modulate synthetic receptors in vivo.

A major metabolite of clozapine used in designer receptor exclusively activated by designer drug, also known as DREADD, technology to modulate synthetic receptors in vivo.

A major metabolite of clozapine used in designer receptor exclusively activated by designer drug, also known as DREADD, technology to modulate synthetic receptors in vivo.

Flumazenil reverses sedative and hypnotic effects of benzodiazepines. It is used to increase acquisition, enhance retention and treat amnesia in mice.

Flumazenil reverses sedative and hypnotic effects of benzodiazepines. It is used to increase acquisition, enhance retention and treat amnesia in mice.

Biochem/physiol Actions Hypnotic anxiolytic ligand for the GABA A receptor benzodiazepine modulatory site. Features and Benefits This compound is a featured product for Neuroscience research.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Application Rc-Ome may be used in GABA A -mediated cell signaling studies. Biochem/physiol Actions Rc-OMe is a GABA A PAM that distinguishes &#945: 1 &#946: 2&#947:2s from &#945: 1 &#946: 2 receptors.